HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout.
HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout.
复制标题
HPRT 相关的高尿酸血症,HPRT1 中出现新的 p.V35M 突变,表现为家族性青少年痛风。
DOI:
10.1007/s13730-020-00459-9
复制
发表时间:
2020
期刊:
影响因子:
1
通讯作者:
Abe T.
中科院分区:
文献类型:
--
作者:
Mishima E;Mori T;Nakajima Y;Toyohara T;Kikuchi K;Oikawa Y;Matsuhashi T;Maeda Y;Suzuki T;Kudo M;Ito S;Sohara E;Uchida S;Abe T.
Unlike complete deficiency of hypoxanthine phosphoribosyltransferase (HPRT) (i.e., Lesch–Nyhan syndrome), partial HPRT deficiency causes HPRT-related hyperuricemia without neurological symptoms. Herein, we describe a 22-year-old man without neurological symptoms that presented gout, hyperuricemia (serum urate level, 12.2 mg/dL), multiple renal microcalculi, and a family history of juvenile gout that was exhibited by his brother and grandfather. Genetic testing revealed a novel missense mutation, c.103G>A (p.V35M), in theHPRT1gene, and biochemical testing (conducted using the patient’s erythrocytes) showed that the patient retained only 12.4% HPRT enzymatic activity compared to that exhibited by a healthy control subject. We thus diagnosed the patient with HPRT-related hyperuricemia caused by partial HPRT deficiency. After his serum urate level was controlled via treatment with febuxostat, his gout did not recur. Thus, this study emphasizes that HPRT deficiency should be considered as a potential cause of familial juvenile gout, even in the absence of neurological symptoms.